Skip to main content
. 2018 May 3;13(5):e0195383. doi: 10.1371/journal.pone.0195383

Table 1. Maternal and neonatal characteristics for the HI and control groups.

  HI Controls p
N 67  113
Maternal age, years 30.5 ± 5.4 30.1 ± 4.5 NS
BMI before pregnancy, kg/m2 23.4 ± 4.2 23.7 ± 5.7 NS
Mean Annual Household income, euros 41172 ± 18358 45472 ± 19309 NS
Gestation number 1.8 ± 1.1 1.6 ± 0.8 NS
Tobacco use during pregnancy 18 (27%) 27 (24%) NS
Gestational weight gain     0.001 
    <10 kg 18 (27%) 33 (29%)   
    10–15 kg 25 (37%) 60 (53%)  
    15–20 kg 12 (18%) 16 (14%)  
    > 20 kg 12 (18%) 4 (4%)  
Gestational diabetes 11 (16%) 19 (17%) NS
    Insulin treatment 4 (6%) 8 (7%) NS
    Regimen alone 7 (10%) 11 (10%) NS
Hypertension 15 (22%) 11 (10%) 0.08
Abnormal fetal heart rate 35 (52%) 11 (10%) <0.001
Cesarean section 37 (55%) 28 (25%) <0.001
Gestational age1, wks 39.0 (37.0; 40.0) 39.3 (37.3; 40.3) NS
Gender (M/F) 43/24 55/58 0.04
Birth weight, kg 2.70 ± 0.85 2.75 ± 0.63 NS
    % of birth weight > 90th perc 8 3 NS
    % of birth weight < 10th perc 50 41 NS
1-minute Apgar score1 9 (8; 10) 9 (8; 10) NS
    % of Apgar score < 5 10 10 NS
% of scalp pH < 7.0 7 4 NS
5-minute Apgar score1 10 (10; 10) 10 (10; 10) NS
Plasma blood glucose, mmol/L 2.1 ± 1.0 *  
Plasma Insulin, IU/L 12.5 ± 18.4  *  

Mean ± SD and Student t test. HI: hyperinsulinism–BMI: body mass index–NS: non significant.

1. Median (25th;75th percentile) and Mann Whitney U test.

*Only capillary blood glucose was measured in controls: values were > 50 mg/dL [2.7 mmol/L] between 4 and 72 hours of life or > 60 mg/dL [3.3 mmol/L] thereafter.